» Articles » PMID: 12841402

Newborn Jaundice and Kernicterus--health and Societal Perspectives

Overview
Specialty Pediatrics
Date 2003 Jul 5
PMID 12841402
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Kernicterus, a preventable injury to the brain from severe neonatal jaundice, has re-emerged in the United States as a public and societal health concern. Kernicterus, in its usually recognized form, causes devastating disabilities, including athetoid cerebral palsy and speech and hearing impairment. This condition not only ranks amongst the highest cost per new case (per CDCs Financial Burden of Disability study, 1992), but also results in profound and uncompromising grief for the family and loss to siblings of healthy, talkative playmates. And for the child with kernicterus (usually remarkably intelligent, but trapped in an uncontrollable body), grief and frustration are enormous. In 2001 national healthcare organizations, including Centers for Disease Control (CDC), the Joint Commission for the Accreditation of Healthcare Organizations (JACHO) and the American Academy of Pediatrics (AAP) issued alerts to all accredited hospitals and public health professionals in the United States that all healthy infants are at potential risk of kernicterus if their newborn jaundice is unmonitored and inadequately treated. The re-emergence of kernicterus in the United States is the result of interacting phenomena including (a) Early hospital discharge (before extent of jaundice is known and signs of impending brain damage have appeared); (b) Lack of adequate concern for the risks of severe jaundice in healthy term and near newborns; (c) An increase in breast feeding; (d) Medical care cost constraints; (e) Paucity of educational materials to enable parents to participate in safeguarding their newborns; and (f) Limitations within in healthcare systems to monitor the outpatient progression of jaundice. A multidisciplinary approach that encompasses both healthcare and societal needs should be evaluated at a national level for practical and easy to implement strategies. An approach that is based on principles of evidence-based medicine, patient-safety and family centeredness is presented in this article. These strategies should also be based on public awareness campaign such that the healthcare providers can attempt to achieve a "Zero Tolerance of Kernicterus" and thereby decrease both childhood disabilities and infant mortality within the community.

Citing Articles

Estimation of the Risk of Hearing Loss in Neonates with Hyperbilirubinemia in the Mysuru District Using Double Stage Double Screening Method.

Mohan B M, Jain C Indian J Otolaryngol Head Neck Surg. 2024; 76(6):5188-5194.

PMID: 39559047 PMC: 11569117. DOI: 10.1007/s12070-024-04937-9.


Application of machine learning algorithms for accurate determination of bilirubin level on in vitro engineered tissue phantom images.

Yuan Y, Huang J, Yu J, Tan J, Chng K, Lee J Sci Rep. 2024; 14(1):5952.

PMID: 38467676 PMC: 10928098. DOI: 10.1038/s41598-024-56319-4.


Validating the early phototherapy prediction tool across cohorts.

Daunhawer I, Schumacher K, Badura A, Vogt J, Michel H, Wellmann S Front Pediatr. 2023; 11:1229462.

PMID: 37876524 PMC: 10593448. DOI: 10.3389/fped.2023.1229462.


The Genetics of Glucose-6-Phosphate-Dehydrogenase (G6PD) and Uridine Diphosphate Glucuronosyl Transferase 1A1 (UGT1A1) Promoter Gene Polymorphism in Relation to Quantitative Biochemical G6PD Activity Measurement and Neonatal Hyperbilirubinemia.

Riskin A, Bravdo Y, Habib C, Maor I, Mousa J, Shahbarat S Children (Basel). 2023; 10(7).

PMID: 37508669 PMC: 10378156. DOI: 10.3390/children10071172.


Fatal Hypernatremic Dehydration in a Term Exclusively Breastfed Newborn.

Del Castillo-Hegyi C, Achilles J, Segrave-Daly B, Hafken L Children (Basel). 2022; 9(9).

PMID: 36138688 PMC: 9498092. DOI: 10.3390/children9091379.


References
1.
Bhutani V, Gourley G, Adler S, Kreamer B, Dalin C, Johnson L . Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics. 2000; 106(2):E17. DOI: 10.1542/peds.106.2.e17. View

2.
Newman T, Klebanoff M . Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal Project. Pediatrics. 1993; 92(5):651-7. View

3.
Bhutani V . Neonatal hyperbilirubinemia and the potential risk of subtle neurological dysfunction. Pediatr Res. 2001; 50(6):679-80. DOI: 10.1203/00006450-200112000-00007. View

4.
Johnson L . Hyperbilirubinemia in the term infant: when to worry, when to treat. N Y State J Med. 1991; 91(11):483-9. View

5.
Newman T, Xiong B, Gonzales V, Escobar G . Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med. 2000; 154(11):1140-7. DOI: 10.1001/archpedi.154.11.1140. View